Litigation Details for Par Pharmaceutical Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2015)
✉ Email this page to a colleague
Par Pharmaceutical Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-06-12 |
| Court | District Court, D. Delaware | Date Terminated | 2016-01-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | Defendant | Referred To | |
| Patents | 7,101,576; 9,040,088 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Par Pharmaceutical Inc. v. Breckenridge Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Par Pharmaceutical Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-06-12 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,040,088;. (dmp, ) (Entered…2015 25 January 2016 1:15-cv-00486 830 Patent Defendant District Court, D. Delaware | External link to document | |
| 2015-09-10 | 41 | continuation-in-part of U.S. Patent No. 7,101,576 ("the '576 patent"). The '576 patent was the subject…asserting infringement of U.S. Patent No. 9,040,088 ("the '088 patent") by TWi and Breckenridge…asserting infringement of three newly issued patents, U.S. Patent Nos. 9, 101,540, 9, 101,549, and 9, 107,827…"defendants"). (D.I. 1) The '088 patent discloses nanoparticulate megestrol formulations…quot;Maryland litigation"). The '576 patent has been held invalid as obvious and not enabled | External link to document | |
| 2016-01-24 | 53 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,040,088. (Attachments: # 1 …2015 25 January 2016 1:15-cv-00486 830 Patent Defendant District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
